article: 1 from 1  
Vojnosanitetski pregled
2009, vol. 66, iss. 6, pp. 487-489
article language: Serbian
Case Report
Unilatelaral iris plateau syndrome after the use of ecstasy
aKlinika za očne bolesti, Klinički centar, Niš
bInstitut za očne bolesti, Klinički centar Srbije, Beograd
cUniversity of Priština, Faculty of Medicine

e-mail: pedjaj@bankerinter.net

Abstract

Bacground. Courmon street name for 3,4-Methylenedioxymethamphetamine (MDMA) is ecstasy. This widely abused 'recreational' drug causes both an increased release of monoamine neurotransmitters, including serotonine and dopamine, and an increased reuptake inhibition of serotonin. As a consequence, mydriasis and increased intraocular pressure (IOP) in predisposed patients occur. We present herein a rare case of acute increased IOP after use of ecstasy. Case report. A female patient, aged 38 years, visited doctor complaing of a decreased vision acuity and severe pain in the left eye and in the left part of the head. The initial treatment was urgent antiglaucomatous therapy followed by withdrawal of subjective problems of the patient and improvement of objective finding. History taking procedure reveled that just before the onset of the pain the patient had used ecstasy and had had similar 'experience' 6 years ago after cocaine snorting. She had not been to a doctor although she had experienced sporadic migrenous pain. Previous medical records excavation of revealed optic disk (cup-to-dise C/D=06), Bjerum arcuate scotoma and iris plateau with narrow chamber angle (Scheie II- III) so the diagnosis was a rare unilateral iris plateau syndrome of the left eye. Although the patient was given some pieces of information about the dangerous and possible deadly consequences of psychoactive substance abuse, she has not continue the treatment. Conclusion. Ecstasy abuse might cause a complete loss of vision, thus medicametous and surgical treatment are obligatory.

Keywords

iris diseases; diagnosis; glaucoma; n-methyl-3,4-methylendioxyamphetamine; substance-related disorders

References

Briley, M., Moret, C. (1993) Neurobiological mechanisms involved in antidepressant therapies. Clin Neuropharmacol, 16(5): 387-400
Craig, J.E., Ong, T.J., Louis, D.L., Wells, J.M. (2004) Mechanism of topiramate-induced acute-onset myopia and angle closure glaucoma. Am J Ophthalmol, 137(1): 193-5
Cvetković, D., Kontić, Đ., Hentova-Senćanić, P. (1996) Glaukom - dijagnoza i lečenje. Beograd: Zavod za udžbenike i nastavna sredstva
Eke, T., Carr, S. (1998) Acute glaucoma, chronic glaucoma, and serotoninergic drugs. Br J Ophthalmol, 82(8): 976-8
Farré, M., de la Torre, R., Mathúna, B.O., Roset, P.N., Peiró, A.M., Torrens, M., Ortuño, J., Pujadas, M., Camí, J. (2004) Repeated doses administration of MDMA in humans: pharmacological effects and pharmacokinetics. Psychopharmacology (Berl), 173(3-4): 364-75
Godel, V., Stein, R., Feiler, V. (1968) Angle-closure glaucoma: following peripheral iridectomy and mydriasis. Am J Ophthalmol, 65(4): 555-60
Gorin, G. (1960) Shortening of the angle of the anterior chamber in angle-closure glaucoma. Am J Ophthalmol, 49(): 141-6
Hassan, L., Carvalho, C., Yannuzzi, L.A., Iida, T., Negrão, S. (2001) Central serous chorioretinopathy in a patient using methylenedioxymethamphetamine (MDMA) or 'ecstasy'. Retina, 21(5): 559-61
He, M., Friedman, D.S., Ge, J., Huang, W., Jin, C., Cai, X., i dr. (2007) Laser peripheral iridotomy in eyes with narrow drainage angles: Ultrasound biomicroscopy outcomes. Liwan Eye Study Ophthalmology, 114(8), str. 1513-9
Jacks, A.S., Hykin, P.G. (1998) Retinal haemorrhage caused by 'ecstasy'. Br J Ophthalmol, 82(7): 842-3
Mccann, U.D., Ridenour, A., Shaham, Y., Ricaurte, G.A. (1994) Serotonin neurotoxicity after (+/-)3,4-methylenedioxymethamphetamine (MDMA; 'Ecstasy'): a controlled study in humans. Neuropsychopharmacology, 10(2): 129-38
Morton, J. (2005) Ecstasy: Pharmacology and neurotoxicity. Curr Opin Pharmacol, 5(1): 79-86
Postel, E.A., Assalian, A., Epstein, D.L. (1996) Drug-induced transient myopia and angle-closure glaucoma associated with supraciliary choroidal effusion. Am J Ophthalmol, 122(1): 110-2
Rhee, D.J., Goldberg, M.J., Parrish, R.K. (2001) Bilateral angle-closure glaucoma and ciliary body swelling from topiramate. Arch Ophthalmol, 119(11): 1721-3
Ritch, R. (1992) Plateau iris is caused by abnormally positioned ciliary processes. Journal of Glaucoma, 1(1): 23
Schroeder, B., Brieden, S. (2000) Bilateral sixth nerve palsy associated with MDMA ('ecstasy') abuse. Am J Ophthalmol, 129(3): 408-9
Tobin, A.B., Unger, W., Osborne, N.N. (1988) Evidence for the presence of serotonergic nerves and receptors in the iris-ciliary body complex of the rabbit. J Neurosci, 8(10): 3713-21
Tripathi, R.C., Tripathi, B.J., Haggerty, C. (2003) Drug-induced glaucomas: Mechanism and management. Drug Saf, 26(11): 749-67
Trittibach, P., Frueh, B.E., Goldblum, D. (2005) Bilateral angle-closure glaucoma after combined consumption of 'ecstasy' and marijuana. American Journal of Emergency Medicine, 23(6): 813
Wand, M., Grant, W.M., Simmons, R.J., Hutchinson, B.T. (1977) Plateau iris syndrome. Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryng, 83(1): 122-30